Connor, Clark & Lunn Investment Management (CC&L)
IONS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Ionis Pharmaceuticals IONS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.5M Buy
265,793
+136,520
+106% +$5.39M 0.04% 389
2025
Q1
$3.9M Buy
129,273
+3,884
+3% +$117K 0.02% 566
2024
Q4
$4.38M Buy
125,389
+107,648
+607% +$3.76M 0.02% 516
2024
Q3
$711K Sell
17,741
-26,515
-60% -$1.06M ﹤0.01% 988
2024
Q2
$2.11M Buy
+44,256
New +$2.11M 0.01% 640
2024
Q1
Sell
-127,954
Closed -$6.47M 1610
2023
Q4
$6.47M Sell
127,954
-1,858
-1% -$94K 0.03% 354
2023
Q3
$5.89M Sell
129,812
-68,696
-35% -$3.12M 0.03% 356
2023
Q2
$8.14M Sell
198,508
-80,250
-29% -$3.29M 0.04% 295
2023
Q1
$9.96M Buy
278,758
+48,181
+21% +$1.72M 0.05% 255
2022
Q4
$8.71M Buy
230,577
+1,516
+0.7% +$57.3K 0.05% 246
2022
Q3
$10.1M Buy
229,061
+97,078
+74% +$4.29M 0.07% 201
2022
Q2
$4.89M Sell
131,983
-25,210
-16% -$933K 0.03% 317
2022
Q1
$5.82M Buy
157,193
+44,668
+40% +$1.65M 0.03% 302
2021
Q4
$3.42M Buy
112,525
+76,989
+217% +$2.34M 0.02% 409
2021
Q3
$1.19M Buy
+35,536
New +$1.19M 0.01% 613
2021
Q2
Sell
-51,579
Closed -$2.32M 1032
2021
Q1
$2.32M Buy
+51,579
New +$2.32M 0.01% 525
2019
Q4
Sell
-18,825
Closed -$1.13M 1010
2019
Q3
$1.13M Buy
+18,825
New +$1.13M 0.01% 520
2018
Q3
Sell
-29,150
Closed -$1.22M 1027
2018
Q2
$1.22M Buy
+29,150
New +$1.22M 0.01% 572
2015
Q4
Sell
-5,900
Closed -$238K 837
2015
Q3
$238K Buy
+5,900
New +$238K ﹤0.01% 623
2014
Q2
Sell
-8,935
Closed -$426K 586
2014
Q1
$426K Sell
8,935
-42,100
-82% -$2.01M ﹤0.01% 509
2013
Q4
$2.16M Sell
51,035
-2,900
-5% -$123K 0.02% 252
2013
Q3
$2.08M Buy
53,935
+6,850
+15% +$264K 0.02% 190
2013
Q2
$1.34M Buy
+47,085
New +$1.34M 0.01% 233